z-logo
open-access-imgOpen Access
Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients
Author(s) -
Dina M. El-Guindy,
Duaa S. Helal,
Nesreen M Sabry,
Mohamed Abo Elnasr
Publication year - 2018
Publication title -
journal of egyptian national cancer institute/journal of the egyptian national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 22
eISSN - 2589-0409
pISSN - 1110-0362
DOI - 10.1016/j.jnci.2018.08.003
Subject(s) - medicine , cd8 , lung cancer , pd l1 , tumor infiltrating lymphocytes , immunotherapy , immunohistochemistry , oncology , cancer , immune system , cancer research , immunology
Cancer immunotherapy targeting programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway has shown promising results in treatment of non-small cell lung cancer (NSCLC) patients. T cells play a major role in tumor-associated immune response. This study aimed to investigate PD-L1 expression alone and combined with CD8 tumor infiltrating lymphocytes (TILs) density in relation to clinicopathologic parameters and survival in NSCLC patients. Immunohistochemical analysis was used to evaluate PD-L1 expression and CD8 TILs density in 55 NSCLC patients. PD-L1 immunopositivity was detected in 36 (65.5%) of NSCLC cases. PD-L1 expression was significantly related to high tumor grade (p value = 0.038) and low CD8 TILs density (p value = 0.004), whereas no significant relations were detected between PD-L1 expression and tumor stage (p value = 0.121), overall survival (OS) (p value = 0.428) and progression-free survival (PFS) (p value = 0.439). Among PD-L1/CD8 TILs density groups, PD-L1 + /CD8 Low group was significantly associated with high tumor grade compared to PD-L1 - /CD8 high group (pairwise p = 0.016). PD-L1 + /CD8 Low group was significantly related to advanced tumor stage compared to PD-L1 + /CD8 high and PD-L1 - /CD8 Low groups (pairwise p = 0.001 and 0.013 respectively). PD-L1 - /CD8 high group exhibited the best OS and PFS whereas PD-L1 + /CD8 low group had the poorest OS and PFS (p value = 0.032 and 0.001 respectively). Assessment of PD-L1 combined with CD8 TILs density, instead of PD-L1 alone, suggested important prognostic relevance in NSCLC patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here